NG

Nathanael S. Gray

DI Dana-Farber Cancer Institute: 11 patents #1 of 192Top 1%
TI The Broad Institute: 1 patents #60 of 207Top 30%
The General Hospital: 1 patents #84 of 426Top 20%
📍 Boston, MA: #11 of 1,303 inventorsTop 1%
🗺 Massachusetts: #100 of 14,338 inventorsTop 1%
Overall (2023): #6,539 of 537,848Top 2%
11
Patents 2023

Issued Patents 2023

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
11827636 Degradation of cyclin-dependent kinase 8 (CDK8) by conjugation of CDK8 inhibitors with E3 ligase ligand and methods of use Tinghu Zhang, Calla M. Olson, Yanke Liang, Nicholas Paul Kwiatkowski 2023-11-28
11826365 Type II raf kinase inhibitors Hwan Geun Choi, Xianming Deng, Jianming Zhang 2023-11-28
11814379 Cyano quinoline amide compounds as HER2 inhibitors and methods of use Jaebong Jang, Pasi Janne, Jieun Son 2023-11-14
11807606 Sulfonamide derivatives for protein degradation Eric Fischer, Hojong Yoon, Tinghu Zhang, Tyler Faust, Katherine Donovan +2 more 2023-11-07
11771697 Small molecule degraders of polybromo-1 (PBRM1) Eric Fischer, Radoslaw Nowak, Katherine Donovan, Tinghu Zhang, Yao Liu 2023-10-03
11730818 Degradation of Bruton's tyrosine kinase (BTK) by conjugation of BTK inhibitors with E3 ligase ligand and methods of use Dennis Dobrovolsky, Hai-Tsang Huang 2023-08-22
11725011 Bicyclic urea kinase inhibitors and uses thereof Yanke Liang, Hwan Geun Choi, Thomas Sundberg, Alykhan Shamji, Ramnik Xavier +2 more 2023-08-15
11712458 Degradation of Bruton's tyrosine kinase (BTK) by conjugation of BTK inhibitors with E3 ligase ligand and methods of use Jinhua Wang, Dennis Dobrovolsky 2023-08-01
11673882 Pyrimidines as EGFR inhibitors and methods of treating disorders Pasi Janne, Hwan Geun Choi, Jaebong Jang 2023-06-13
11584746 Inhibitors of EGFR and methods of use thereof Dries De Clercq, Jaebong Jang, Pasi Janne, Ciric To, Michael Eck +2 more 2023-02-21
11542251 IRAK degraders and uses thereof John Hatcher 2023-01-03